- Home
- SINT vs BOLT Comparison
SINT vs BOLT Comparison
Compare SINT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SINT | BOLT |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 10.5M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SINT | BOLT |
|---|---|---|
| Price | $2.72 | $4.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $16.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 30.8K | 27.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.84 |
| EPS | ★ N/A | N/A |
| Revenue | $2,887,000.00 | ★ $7,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $80.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.90 | N/A |
| 52 Week Low | $1.72 | $0.26 |
| 52 Week High | $6.78 | $7.35 |
Technical Indicators
Market Signals| Indicator | SINT | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 37.82 |
| Support Level | $2.55 | $0.28 |
| Resistance Level | $2.94 | $5.45 |
| Average True Range (ATR) | 0.13 | 0.40 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 9.26 | 16.35 |
Price Performance
Historical ComparisonAbout SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.